Apoptosis in the vasculature: Mechanisms and functional importance

British Journal of Pharmacology

Volumn 130, Issue 5, 2000, Pages 947-962

  Mallat, Ziad ^a   Tedgui, Alain ^a  

^a INSERM   (France)

Author keywords

Apoptosis; Atherosclerosis; Caspases; Endothelial cell; Macrophage; Smooth muscle cell; Thrombosis

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 10; NITRIC OXIDE; VASCULOTROPIN;

APOPTOSIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL SURVIVAL; HUMAN; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; REVIEW; SIDE EFFECT; SMOOTH MUSCLE FIBER; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASCULARIZATION;

EID: 0033935921     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703407     Document Type: Review

References (167)

1. ALON, T., HEMO, I., ITIN, A., PE'ER, J., STONE, J. & KESHET, E. (1995). Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med., 1, 1024-1028.
2. ALVAREZ, R.J., GIPS, S.J., MOLDOVAN, N., WILHIDE, C.C., MILLIKEN, E.E., HOANG, A.T., HRUBAN, R.H., SILVERMAN, H.S., DANG, C.V. & GOLDSCHMIDT-CLERMONT, P.J. (1997). 17β-estradiol inhibits apoptosis of endothelial cells. Biochem. Biophys. Res. Commun., 237, 372-381.
3. ARNAL, J.F., CLAMENS, S., PECHET, C., NEGRESALVAYRE, A., ALLERA, C., GIROLAMI, J P., SALVAYRE, R. & BAYARD, F. (1996). Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production. Proc. Natl. Acad. Sci. U.S.A., 93, 4108-4113.
4. ASHKENAZI, A. & DIXIT, V.M. (1998). Death receptors: signaling and modulation. Science, 281, 1305-1308.
5. AUPEIX, K., HUGEL, B., MARTIN, T., BISCHOFF, P., LILL, H., PASQUALI, J.E. & FREYSSINET, J.M. (1997). The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. J. Clin. Invest., 99, 1546-1554.
6. BACH, F.H., FERRAN, C, HECHENLEITNER, P., MARK, W., KOYAMADA, N., MIYATAKE, T., WINKLER, H., BADRICHANI, A., CANDINAS, D. & HANCOCK, W.W. (1997). Accommodation of vascularized xenografts: Expression of 'protective genes' by donor endothelial cells in a host Th2 cytokine environment. Nature Med., 3, 196-204.
7. BACH, R., GENTRY, R. & NEMERSON, Y. (1986). Factor VII binding to tissue factor in reconstituted phospholipid vesicles: induction of cooperatively by phosphatidylserine. Biochemistry, 25, 4007-4020.
8. 1. serve an anti-inflammatory function in endothelial cells through inhibition of NF-κB. J. Clin. Invest., 103, 543-553.
9. BAI, H., POLLMAN, M.J., INISHI, Y. & GIBBONS, G.H. (1999). Regulation of vascular smooth muscle cell apoptosis. Modulation of bad by a phosphatidylinositol 3-kinase-dependent pathway. Circ. Res., 85, 229-237.
10. BAKER, A.H., ZALTSMAN, A.B., GEORGE, S.J. & NEWBY, A.C. (1998). Divergent effects of tissue inhibitor of metalloproteinase-1,-2 or-3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. J. Clin. Invest., 101, 1478-1487.
11. BAURIEDEL, G., SCHLUCKEBIER, S., HUTTER, R., WELSCH, U., KANDOLF, R., LÜDERITZ, B. & PRESCOTT, M.F. (1998). Apoptosis in restenosis versus stable-angina atherosclerosis. Implications for the pathogenesis of restenosis. Arterioscler. Thromb. Vasc. Biol., 18, 1132-1139.
12. BENNETT, M.R., EVAN, G.I. & NEWBY, A.C. (1994). Deregulated expression of the c-myc oncogene abolishes inhibition of proliferation of rat vascular smooth muscle cells by serum reduction, interferon-γ, heparin, and cyclic nucleotide analogues and induces apoptosis. Circ. Res., 74, 525-536.
13. BENNETT, M.R., EVAN, G.I. & SCHWARTZ, S.M. (1995a). Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and -independent pathways. Circ. Res., 77, 266-273.
14. BENNETT, M.R., EVAN, G.I. & SCHWARTZ, S.M. (1995b). Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J. Clin. Invest., 95, 2266-2274.
15. BENNETT, M.R., LITTLEWOOD, T.D., SCHWARTZ, S.M. & WEISSBERG, P.L. (1997). Increased sensitivity of human vascular smooth muscle cells from atherosclerotic plaques to p53-mediated apoptosis. Circ. Res., 81, 591-599.
16. BENNETT, MR., MACDONALD, K., CHAN, S.W., BOYLE, J.J. & WEISSBERG, P.L. (1998a). Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques. Circ. Res., 82, 704-712.
17. BENNETT, M.R., MACDONALD, K., CHAN, S.W., LUZIO, J.P., SIMARI, R. & WEISSBERG, P. (1998b). Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science, 282, 290-293.
18. BIRD, D.A., GILLOTTE, K.L., HORKKO, S., FRIEDMAN, P., DENNIS, E.A., WITZTUM, J.L. & STEINBERG, D. (1999). Receptors for oxidized low-density lipoprotein on elicited mouse peritoneal macrophages can recognize both the modified lipid moieties and the modified protein moieties: implications with respect to macrophage recognition of apoptotic cells. Proc. Natl. Acad. Sci. U.S.A., 96, 6347-6352.
19. BJÖRKERUD, S. & BJÖRKERUD, B. (1996). Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am. J. Pathol., 149, 367-380.
20. BOCHATON-PIALLAT, M.L., GABBIANI, F., REDARD, M., DESMOULIÈRE, A. & GABBIANI, G. (1995). Apoptosis participates in cellularity regulation during rat aortic intimal thickening. Am. J. Pathol., 146, 1059-1064.
21. BOMBELI, T., KARSAN, A., TAIT, J.F. & HARLAN, J.M. (1997). Apoptotic vascular endothelial cells become procoagulant. Blood, 89, 2429-2442.
22. BOYLE, J.J., BOWYER, D.E., PROUDFOOT, D., WEISSBERG, P.L. & BENNETT, M.R. (1998). Human monocyte/macrophages induce human vascular smooth muscle cell apoptosis in culture. Circulation, 98, 1-598. Abstract.
23. BRANDL, R., RICHTER, T., HAUG, K., WILHELM, M.G., MAURER, P.C. & NATHRATH, W. (1997). Topographic analysis of proliferative activity in carotid endarterectomy specimens by immunocytochemical detection of the cell cycle-related antigen Ki-67. Circulation, 96, 3360-3368.
24. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell, 79, 1157-1164.
25. CAI, W., DEVAUX, B., SCHAPER, W. & SCHAPER, J. (1997). The role of Fas/APO I and apoptosis in the development of human atherosclerotic lesions. Atherosclerosis, 131, 177-186.
26. CARMELIET, P., LAMPUGNANI, M.G., MOONS, L., BREVIARIO, F., COMPERNOLLE, V., BONO, F., BALCONI, G., SPAGNUOLO, R., OOSTUYSE, B., DEWERCHIN, M., ZANETTI, A., ANGELLILO, A., MATTOT, V., NUYENS, D., LUTGENS, E., CLOTMAN, F., DE RUITER, M.C., GITTENBERGER-DE-GROOT, A., POELMANN, R., LUPU, F., HERBERT, J.M., COLLEN, D. & DEJANA, E. (1999). Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell, 98, 147-157.
27. CASCIOLA-ROSEN, L.A., ANHALT, G. & ROSEN, A. (1994). Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med., 179, 1317-1330.
28. CHANG, M.K., BERGMARK, C., LAURILA, A., HORKKO, S., HAN, K.H., FRIEDMAN, P., DENNIS, E.A. & WITZTUM, J.L. (1999). Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc. Natl. Acad. Sci. U.S.A., 96, 6353-6358.
29. CHO, A., COURTMAN, D.W. & LANGILLE, B.L. (1995). Apoptosis (programmed cell death) in arteries of the neonatal lamb. Circ. Res., 76, 168-175.
30. CLAESSON-WELSH, L., WELSH, M., ITO, N., ANAND-APTE, B., SOKER, S., ZETTER, B., O'REILLY, M. & FOLKMAN, J. (1998). Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD. Proc. Natl. Acad. Sci. U.S.A., 95, 5579-5583.
31. CLIFF, W.J. (1970). The aortic tunica media in aging rats. Exp. Mol. Pathol., 13, 172-189.
32. 3), reduces neointimal hyperplasia and total vessel area after balloon injury in hypercholesterolemic rabbits. Circ. Res., 84, 1268-1276.
33. DEVITT, A., MOFFATT, O.D., RAYKUNDALIA, C., CAPRA, J.D., SIMMONS, D.L. & GREGORY, C.D. (1998). Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature, 392, 505-509.
34. DIEZ, J., FORTUNO, M.A. & RAVASSA, S. (1998). Apoptosis in hypertensive heart disease. Curr. Opin. Cardiol., 13, 317-325.
35. DIMMELER, S., ASSMUS, B., HERMANN, C., HAENDELER, J. & ZEIHER, A.M. (1998). Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells: involvement in suppression of apoptosis. Circ. Res., 83, 334-341.
36. DIMMELER, S., BREITSCHOPF, K., HAENDELER, J. & ZEIHER, A.M. (1999b). Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway. J. Exp. Med., 189, 1815-1822.
37. DIMMELER, S., FLEMING, I., FISSLTHALER, B., HERMANN, C., BUSSE, R. & ZEIHER, A.M. (1999a). Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature, 399, 601-605.
38. DIMMELER, S., HAENDELER, J., GALLE, J. & ZEIHER, A.M. (1997a). Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases: A mechanistic clue to the 'response to injury' hypothesis. Circulation, 95, 1760-1763.
39. DIMMELER, S., HAENDELER, J., NEHLS, M. & ZEIHER, A.M. (1997b). Suppression of apoptosis by nitric oxide via inhibition of interleukin-1 beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J. Exp. Med., 185, 601-607.
40. DIMMELER, S., HAENDELER, J., RIPPMANN, V., NEHLS, M. & ZEIHER, A.M. (1996). Shear stress inhibits apoptosis of human endothelial cells. FEBS Lett., 399, 71-74.
41. DIMMELER, S., RIPPMANN, V., WEILAND, U., HAENDELER, J. & ZEIHER, A.M. (1997c). Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide. Circ. Res., 81, 970-976.
42. DIMMELER, S. & ZEIHER, A.M. (1999). Nitric oxide-an endothelial cell survival factor. Cell Death Differ., 6, 964-968.
43. DONG, C., WILSON, J.E., WINTERS, G.L. & MCMANUS, B.M. (1996). Human transplant coronary artery disease: Pathological evidence for Fas-mediated apoptotic cytotoxicity in allograft arteriopathy. Lab. Invest., 74, 921-931.
44. DOWNING, L.J., STRIETER, R.M., KADELL, A.M., WILKE, C.A., AUSTIN, J.C., HARE, B.D., BURDICK, M.D., GREENFIELD, L.J. & WAKEFIELD, T.W. (1998). IL-10 regulates thrombus-induced vein wall inflammation and thrombosis. J. Immunol., 161, 1471-1476.
45. DUFOURCQ, P., LOUIS, H., MOREAU, C., DARET, D., BOISSEAU, M.R., LAMAZIERE, J.M. & BONNET, J. (1998). Vitronectin expression and interaction with receptors in smooth muscle cells from human atheromatous plaque. Arterioscler. Thromb. Vasc. Biol., 18, 168-176.
46. ENARI, M., SAKAHIRA, H., YOKOYAMA, H., OKAWA, K., IWAMATSU, A. & NAGATA, S. (1998). A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature, 391, 43-50.
47. ERNOFSSON, M., TENNO, T. & SIEGBAHN, A. (1996). Inhibition of tissue factor surface expression in human peripheral blood monocytes exposed to cytokines. Br. J. Haematol., 95, 249-257.
48. ESCARGUEIL-BLANC, I., MEILHAC, O., PIERAGGI, M.-T., ARNAL, J.-F., SALVAYRE, R. & NÈGRE-SALVAYRE, A. (1997). Oxidized LDLs induce massive apoptosis of cultured human endothelial cells through a calcium-dependent pathway: prevention by aurintricarboxylic acid. Arterioscler. Thromb. Vasc. Biol., 17, 331-339.
49. EVAN, G.I., WYLLIE, A.H., GILBERT, C.S., LITTLEWOOD, T.D., LAND, H., BROOKS, M., WATERS, C.M., PENN, L.Z. & HANCOCK, D.C. (1992). Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69, 119-128.
50. FADOK, V.A., SAVILL, J.S., HASLETT, C., BRATTON, D.L., DOHERTY, D.E., CAMPBELL, P.A. & HENSON, P.M. (1992). Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J. Immunol., 149, 4029-4035.
51. 3). J. Immunol., 161, 6250-6257.
52. FERRIS, C.D., JAFFREY, S.R., SAWA, A., TAKAHASHI, M., BRADY, S.D., BARROW, R.K., TYSOE, S.A., WOLOSKER, H., BARANANO, D.E., DORE, S., POSS, K.D. & SNYDER, S.H. (1999). Haem oxygenase-1 prevents cell death by regulating cellular iron. Nat. Cell. Biol., 1, 152-157.
53. FLYNN, P.D., BYRNE, C.D., BAGLIN, T.P., WEISSBERG, P.L. & BENNETT, M.R. (1997). Thrombin generation by apoptotic vascular smooth muscle cells. Blood, 89, 4378-4384.
54. FOX, J.C. & SHANLEY, J.R. (1996). Antisense inhibition of basic fibroblast growth factor induces apoptosis in vascular smooth muscle cells. J. Biol. Chem., 271, 12578-12584.
55. FUJIKAWA, K., DE AOS SCHERPENSEEL, I., JAIN, S.K., PRESMAN, E. & VARTICOVSKI, L. (1999). Role of PI 3-kinase in angiopoietin-1-mediated migration and attachment-dependent survival of endothelial cells [In Process Citation]. Exp. Cell. Res., 253, 663-672.
56. GALIS, Z.S., SUKHOVA, G.K., LARK, M.W. & LIBBY, P. (1994). Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest., 94, 2493-2503.
57. GENG, Y.J., HENDERSON, L.E., LEVESQUE, E.B., MUSZYNSKI, M. & LIBBY, P. (1997). Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol., 17, 2200-2208.
58. GENG, Y.-J. & LIBBY, P. (1995). Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1β-converting enzyme. Am. J. Pathol., 147, 251-266.
59. GENG, Y.J., WU. Q., MUSZYNSKI, M., HANSSON, G.K. & LIBBY, P. (1996). Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta. Arterioscler. Thromb. Vasc. Biol., 16, 19-27.
60. GERBER, H.P., DIXIT, V. & FERRARA, N. (1998). Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and Al in vascular endothelial cells. J. Biol. Chem., 273, 13313-13316.
61. GIDON-JEANGIRARD, C., HUGEL, B., HOLL, V., TOTI, F., LAPLANCHE, J.L., MEYER, D. & FREYSSINET, J.M. (1999). Annexin V delays apoptosis while exerting an external constraint preventing the release of CD4+ and PrPc+ membrane particles in a human T lymphocyte model. J. Immunol., 162, 5712-5718.
62. GOLSTEIN, P. (1997). Controlling cell death. Science, 275, 1081-1082.
63. GOPING, I.S., GROSS, A., LAVOIE, J.N., NGUYEN, M., JEMMERSON, R., ROTH, K., KORSMEYER, S.J. & SHORE, G.C. (1998). Regulated targeting of BAX to mitochondria. J. Cell Biol., 143, 207-215.
64. GORDON, D., REIDY, M.A., BENDITT, E.P. & SCHWARTZ, S.M. (1990). Cell proliferation in human coronary arteries. Proc. Natl. Acad. Sci. U.S.A., 87, 4600-4604.
65. GREEN, D. & KROEMER, G. (1998). The central executioners of apoptosis: caspases or mitochondria? Trends Cell. Biol., 8, 267-271.
66. GREEN, D.R. & REED, J.C. (1998). Mitochondria and apoptosis. Science, 281, 1309-1311.
67. GRIFFITHS, G.J., DUBREZ, L., MORGAN, C.P., JONES, N.A., WHITE-HOUSE, J., CORFE, B.M., DIVE, C. & HICKMAN, J.A. (1999). Cell damage-induced conformational changes of the pro-apoptotic protein Bak in vivo precede the onset of apoptosis. J. Cell Biol., 144, 903-914.
68. HAENDELER, J., ZEIHER, A.M. & DIMMELER, S. (1996). Vitamin C and E prevent lipopolysaccharide-induced apoptosis in human endothelial cells by modulation of Bcl-2 and Bax. Eur. J. Pharmacol., 317, 407-411.
69. HAIMOVITZ-FRIEDMAN, A., CORDON-CARDO, C., BAYOUMY, S., GARZOTTO, M., MCLOUGHLIN, M., GALLILY, R., EDWARDS, III, C.K., SCHUCHMAN, E.H., FUKS, Z. & KOLESNICK, R. (1997). Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J. Exp. Med., 186, 1831-1841.
70. HAMET, P., MOREAU, P., DAM, T.V., ORLOV, S.N., TEA, B.S., DEBLOIS, D. & TREMBLAY, J. (1996). The time window of apoptosis: A new component in the therapeutic strategy for cardiovascular remodeling. J. Hypertens., 14, S65-S70.
71. HAN, D.K.M., HAUDENSCHILD, C.C., HONG, M.K., TINKLE, B.T., LEON, M.B. & LIAU, G. (1995). Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am. J. Pathol., 147, 267-277.
72. HAN, D.K.M., WRIGHT, M.E., DIXIT, V.M., PRUIT, R., SON SOE, M., LYNCH, D.H. & SCHWARTZ, S.M. (1996). Evidence for escape of apoptosis by a loss of Fas in atherosclerotic plaque smooth muscle cells. Circulation, 94 (suppl I), I-397.
73. HANCOCK, W.W., BUELOW, R., SAYEGH, M.H. & TURKA, L.A. (1998). Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat. Med., 4, 1392-1396.
74. HARADA-SHIBA, M., KINOSHITA, M., KAMIDO, H. & SHIMOKADO, K. (1998). Oxidized low density lipoprotein induces apoptosis in cultured human umbilical vein endothelial cells by common and unique mechanisms. J. Biol. Chem., 273, 9681-9687.
75. HAUNSTETTER, A. & IZUMO, S. (1998). Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ. Res., 82, 1111-1129.
76. HAYES, A.J., HUANG, W.Q., MALLAH, J., YANG, D., LIPPMAN, M.E. & LI, L.Y. (1999). Angiopoietin-1 and its receptor Tie-2 participate in the regulation of capillary-like tubule formation and survival of endothelial cells. Microvasc. Res., 58, 224-237.
77. HEGYI, L., SKEPPER, J.N., CARY, N.R. & MITCHINSON, M.J. (1996). Foam cell apoptosis and the development of the lipid core of human atherosclerosis. J. Pathol., 180, 423-442.
78. HERMANN, C., ZEIHER, A.M. & DIMMELER, S. (1997). Shear stress inhibits H2O2-induced apoptosis of human endothelial cells by modulation of the glutathione redox cycle and nitric oxide synthase. Arterioscler. Thromb. Vasc. Biol., 17, 3588-3592.
79. HERREN, B., LEVKAU, B., RAINES, E.W. & ROSS, R. (1998). Cleavage of beta-catenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis: evidence for a role for caspases and metalloprotcinases. Mol. Biol. Cell, 9, 1589-1601.
80. HESSLER, J.L., ROBERTSON, A.L. & CHISOLM, G.M. (1979). LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis, 32, 213-229.
81. HETTS, S.W. (1998). To die or not to die: an overview of apoptosis and its role in disease. JAMA, 279, 300-307.
82. HOLASH, J., MAISONPIERRE, P.C., COMPTON, D., BOLAND, P., ALEXANDER, C.R., ZAGZAG, D., YANCOPOULOS, G.D. & WIEGAND, S.J. (1999). Vessel cooption, regression, and growth in tumors mediated by angiopoiteins and VEGF. Science, 284, 1994-1998.
83. HOWARD, M., MUCHAMEL, T., ANDRADE, S. & MENON, S. (1993). Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med., 177, 1205-1208.
84. ILIC, D., ALMEIDA, E.A., SCHLAEPFER, D.D., DAZIN, P., AIZAWA, S. & DAMSKY, C.H. (1998). Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. J. Cell. Biol., 143, 547-560.
85. ISNER, J.M., KEARNEY, M., BORTMAN, S. & PASSERI, J. (1995). Apoptosis in human atherosclerosis and restenosis. Circulation, 91, 2703-2711.
86. JONES, P.L., COWAN, K.N. & RABINOVITCH, M. (1997b). Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease. Am. J. Pathol., 150, 1349-1360.
87. 3 integrin to promote epidermal growth factor receptor phosphorylation and growth. J. Cell Biol., 139, 279-293.
88. JORINGE, S., CRISBY, M., THYBERG, J. & NILSSON, J. (1997). DNA fragmentation and ultrastructural changes of degenerating cells in atherosclerotic lesions and smooth muscle cells exposed to oxidized LDL in vitro. Arterioscler. Thromb. Vasc. Biol., 17, 2225-2231.
89. KAISER, D., FREYBERG, M.A. & FRIEDL, P. (1997). Lack of hemodynamic forces triggers apoptosis in vascular endothelial cells. Biochem. Biophys. Res. Commun., 231, 586-590.
90. KARSAN, A. (1998). Tumor necrosis factor and endothelial cell death. Trends Cardiovasc. Med., 8, 19-24.
91. KARSAN, A., YEE, E., KAUSHANSKY, K. & HARLAN, J.M. (1996). Cloning of a human Bcl-2 homologue: Inflammatory cytokines induce human Al in cultured endothelial cells. Blood, 87, 3089-3096.
92. KARSAN, A., YEE, E., POIRIER, G.G., ZHOU, P., CRAIG, R. & HARLAN, J.M. (1997). Fibroblast growth factor-2 inhibits endothelial cell apoptosis by Bcl-2 dependent and independent mechanisms. Am. J. Pathol., 151, 1775-1784.
93. KATOH, O., TAUCHI, H., KAWAISHI, K., KIMURA, A & SATOW, Y. (1995). Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation. Cancer Res., 55, 5687-5692.
94. KERR, J.F.R., WYLLIE, A.H. & CURRIE, A.R. (1972). Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 26, 239-257.
95. KIM, Y.M., BOMBECK, C.A. & BILLIAR, T.R. (1999). Nitric oxide as a bifunctional regulator of apoptosis. Circ. Res., 84, 253-256.
96. KOCKX, M.M., DEMEYER, G.R.Y., MUHRING, J., BULT, H., BULTINCK, J. & HERMAN, A.G. (1996). Distribution of cell replication and apoptosis in atherosclerotic plaques of cholesterol-fed rabbits. Atherosclerosis, 120, 115-124.
97. KOCKX, M.M., DE MEYER, G.R.Y., MUHRING, J., JACOB, W., BULT, H. & HERMAN, A.G. (1998). Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation, 97, 2307-2315.
98. KOYAMA, H., RAINES, E.W., BORNFELDT, K.E., ROBERTS, J.M. & ROSS, R. (1996). Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell, 87, 1069-1078.
99. KROEMER, G. (1997). The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med., 3, 614-620.
100. KROEMER, G., ZAMZAMI, N. & SUSIN, S.A. (1997). Mitochondrial control of apoptosis. Immunol. Today, 18, 44-51.
101. KWAK, H.J., SO, J.N., LEE, S.J., KIM, I. & KOH, G.Y. (1999). Angiopoietin-1 is an apoptosis survival factor for endothelial cells. FEBS Lett., 448, 249-253.
102. LANG, R.A. & BISHOP, J.M. (1993). Macrophages are required for cell death and tissue remodeling in the developing mouse eye. Cell, 74, 453-462.
103. LESZCZYNSKI, D., ZHAO, Y., LUOKKAMÄKI, M. & FOEGH, M.L. (1994). Apoptosis of vascular smooth muscle cells. Protein kinase C and oncoprotein Bcl-2 are involved in regulation of apoptosis in non-transformed rat vascular smooth muscle cells. Am. J. Pathol., 145, 1265-1270.
104. LEVINE, J.S. & KOH, J.S. (1999). The role of apoptosis in autoimmunity: immunogen, antigen, and accelerant. Semin. Nephrol., 19, 34-47.
105. LEVKAU, B., HERREN, B., KOYAMA, H., ROSS, R. & RAINES, E.W. (1998). Caspase-mediated cleavage of focal adhesion kinase pp125FAK and disassembly of focal adhesions in human endothelial cell apoptosis. J. Exp. Med., 187, 579-586.
106. LEVKAU, B., SCATENA, M., GIACHELLI, C.M., ROSS, R. & RAINES, E.W. (1999). Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-κB loop. Nat. Cell. Biol., 1, 227-233.
107. LI, D., TOMSON, K., YANG, B., MEHTA, P., CROKER, B.P. & MEHTA, J.L. (1999a). Modulation of constitutive nitric oxide synthase, bcl-2 and Fas expression in cultured human coronary endothelial cells exposed to anoxia-reoxygenation and angiotensin II: role of AT1 receptor activation. Cardiovasc. Res., 41, 109-115.
108. LI, D., YANG, B., PHILIPS, M.I. & MEHTA, J.L. (1999b). Proapoptotic effects of ANG II in human coronary artery endothelial cells: role of AT1 receptor and PKC activation. Am. J. Physiol., 276, H786-H792.
109. LINDNER, H., HOLLER, E., ERTL, B., MULTHOFF, G., SCHREGLMANN, M., KLAUKE, I., SCHULTZ-HECTOR, S. & EISSNER, G. (1997). Peripheral blood mononuclear cells induce programmed cell death in human endothelial cells and may prevent repair: role of cytokines. Blood, 89, 1931-1938.
110. LIU, X., ZOU, H., SLAUGHTER, C. & WANG, X. (1997). DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell, 89, 175-184.
111. LIZARD, G., DECKERT, V., DUBREZ, L., MOISANT, M., GAMBERT, P. & LAGROST, L. (1996). Induction of apoptosis in endothelial cells treated with cholesterol oxides. Am. J. Pathol., 148, 1625-1638.
112. LUCAS, R., HOLMGREN, L., GARCIA, I., JIMENEZ, B., MANDRIOTA, S.J., BORLAT, F., SIM, B.K., WU, Z., GRAU, G.E., SHING, Y., SOFF, G.A., BOUCK, N. & PEPPER, M.S. (1998). Multiple forms of angiostatin induce apoptosis in endothelial cells. Blood, 92, 4730-4741.
113. MAJNO, G. & JORIS, I. (1995). Apoptosis, oncosis, and necrosis. Am. J. Pathol., 146, 3-15.
114. MALLAT, Z., BENAMER, H., HUGEL, B., BENESSIANO, J., STEG, P.G., FREYSSINET, J.M. & TEDGUI, A. (2000). Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation, 101, 841-843.
115. MALLAT, Z., BESNARD, S., DURIEZ, M., DELEUZE, V., EMMANUEL, F., BUREAU, M.F., SOUBRIER, F., ESPOSITO, B., DUEZ, H., FIEVET, C., STAELS, B., DUVERGER, N., SCHERMAN, D. & TEDGUI, A. (1999c). Protective role of interleukin-10 in atherosclerosis. Circ. Res., 85, e17-e24.
116. MALLAT, Z., HEYMES, C., OHAN, J., FAGGIN, E., LESÈCHE, G. & TEDGUI, A. (1999a). Expression of interleukin-10 in advanced human atherosclerotic plaques. Relation to inducible nitric oxide synthase expression and cell death. Arterioscler. Thromb. Vasc. Biol., 19, 611-616.
117. MALLAT, Z., HUGEL, B., OHAN, J., LESÈCHE, G., FREYSSINET, J.M. & TEDGUI, A. (1999b). Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques. A role for apoptosis in plaque thrombogenicity. Circulation, 99, 348-353.
118. MALLAT, Z., OHAN, J., LESÈCHE, G. & TEDGUI, A. (1997). Colocalization of CPP-32 with apoptotic cells in human atherosclerotic plaques. Circulation, 96, 424-428.
119. MARTIN, S.J., REUTELINGSPERGER, C.P.M., MCGAHON, A.J., RADER, J.A., VAN SCHIE, R.C.A., LAFACE, D.M. & GREEN, D.R. (1995). Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med., 182, 1545-1556.
120. MASON, C.A., BIGRAS, J.L., O'BLENES, S.B., ZHOU, B., MCINTYRE, B., NAKAMURA, N., KANEDA, Y. & RABINOVITCH, M. (1999). Gene transfer in utero biologically engineers a patent ductus arteriosus in lambs by arresting fibronectin-dependent neointimal formation. Nat. Med., 5, 176-182.
121. MEESON, A., PALMER, M., CALFON, M. & LANG, R. (1996). A relationship between apoptosis and flow during programmed capillary regression is revealed by vital analysis. Development, 122, 3929-3938.
122. MEREDITH, J., FAZELI, B. & SCHWARTZ, M. (1993). The extra-cellular matrix as a survival factor. Mol. Biol. Cell, 4, 953-961.
123. MEVORACH, D., MASCARENHAS, J.O., GERSHOV, D. & ELKON, K.B. (1998). Complement-dependent clearance of apoptotic cells by human macrophages. J. Exp. Med., 188, 2313-2320.
124. MIOSSEC, C., DUTILLEUL, V., FASSY, F. & DIUHERCEND, A. (1997). Evidence for CPP32 activation in the absence of apoptosis during T lymphocyte stimulation. J. Biol. Chem., 272, 13459-13462.
125. MORISHITA, R., GIBBONS, G.H., ELLISON, K.E., LEE, W., ZHANG, L.N., YU, H., KANEDA, Y., OGIHARA, T. & DAZU, V.J. (1994). Evidence for direct local effect of angiotensin in vascular hypertrophy-in vivo gene transfer of angiotensin converting enzyme. J. Clin. Invest., 94, 978-984.
126. MOULTON, K.S., HELLER, E., KONERDING, M.A., FLYNN, E., PALINSKI, W. & FOLKMAN, J. (1999). Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation, 90, 1726-1732.
127. NICHOLSON, D.W., ALI, A., THORNBERRY, N.A., VAILLANCOURT, J.P., DING, C.K., GALLANT, M., GAREAU, Y., GRIFFIN, P.R., LABELLE, M., LAZEBNIK, Y.A., MUNDAY, N.A., RAJU, S.M., SMULSON, M.E., YAMIN, T.-T., YU, V.L. & MILLER, D.K. (1995). Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature, 376, 37-43.
128. NISHIO, E. & WATANABE, Y. (1996). Oxysterols induced apoptosis in cultured smooth muscle cells through CPP32 protease activation and BCL-2 protein downregulation. Biochem. Biophys. Res. Commun., 226, 928-934.
129. NOBLE, K.E., WICKREMASINGHE, R.G., DECORNET, C., PANAYIOTIDIS, P. & YONG, K.L. (1999). Monocytes stimulate expression of the Bcl-2 family member, Al, in endothelial cells and confer protection against apoptosis. J. Immunol., 162, 1376-1383.
130. PARKES, J.L., CARDELL, R.R., HUBBARD, F.C.J., HUBBARD, D., MELTZER, A. & PENN, A. (1991). Cultured human atherosclerotic plaque smooth muscle cells retain transforming potential and display enhanced expression of the myc protooncogene. Am. J. Pathol., 138, 765-775.
131. PERLMAN, H., MAILLARD, L., KRASINSKI, K. & WALSH, K. (1997). Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation, 95, 981-987.
132. POLLMAN, M.J., HALL, J.L. & GIBBONS, G.H. (1999b). Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury: influence of redox state and cell phenotype. Circ. Res., 84, 113-121.
133. POLLMAN, M.J., HALL, J.L., MANN, M.J., ZHANG, L. & GIBBONS, G.H. (1998). Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease. Nat. Med., 4, 222-227.
134. POLLMAN, M.J., NAUMOVSKI, L. & GIBBONS, G.H. (1999a). Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-β1 in endothelial cells versus smooth muscle cells. Circulation, 99, 2019-2026.
135. POLLMAN, M.J., YAMADA, T., HORIUCHI, M & GIBBONS, G.H. (1996). Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II. Circ. Res., 79, 748-756.
136. RE, F., ZANETTI, A., SIRONI, M., POLENTARUTTI, N., LANFRANCONE, L., DEJANA, E. & COLOTTA, F. (1994). Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells. J. Cell Biol., 127, 537-546.
137. RICHARDSON, B.C., LALWANI, N.D., JOHNSON, K.J. & MARKS, R.M. (1994). Fas ligation triggers apoptosis in macrophages but not endothelial cells. Eur. J. Immunol., 24, 2640-2645.
138. ROSEN, A., CASCIOLA-ROSEN, L. & AHEARN, J. (1995). Novel packages of viral and self-antigens are generated during apoptosis. J. Exp. Med., 181, 1557-1561.
139. ROSS, R. (1999). Atherosclerosis an inflammatory disease. N. Engl. J. Med., 340, 115-126.
140. ROUIS, M., ADAMY, C., DUVERGER, N., LESNIK, P., HORELLOU, P., MOREAU, M., EMMANUEL, F., CAILLAUD, J.M., LAPLAUD, P.M., DACHET, C. & CHAPMAN, M.J. (1999). Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E-deficient mice. Circulation, 100, 533-540.
141. 3 in the disruption of the tumor vasculature induced by TNF and IFN-γ. Nat. Med., 4, 408-413.
142. SAKAHIRA, H., ENARI, M. & NAGATA, S. (1998). Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature, 391, 96-99.
143. SATA, M., PERLMAN, H., MURUVE, D.A., SILVER, M., IKEBE, M., LIBERMANN, T.A., OETTGEN, P. & WALSH, K. (1998). Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response. Proc. Natl. Acad. Sci. U.S.A., 95, 1213-1217.
144. SATA, M. & WALSH, K. (1998). Oxidized LDL activates Fas-mediated endothelial cell apoptosis. J. Clin. Invest., 102, 1682-1689.
145. SAVILL, J., FADOK, V., HENSON, P. & HASLETT, C. (1993). Phagocyte recognition of cells undergoing apoptosis. Immunol. Today, 14, 131-136.
146. SCATENA, M., ALMEIDA, M., CHAISSON, M.L., FAUSTO, N., NICOSIA, R.F. & GIACHELLI, C.M. (1998). NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival. J. Cell Biol., 141, 1083-1093.
147. SCHAUB, F.J.W., COATS, S.A., SEIFERT, R.A., RAMACHANDRAN, R.K., HAN, D.K.M. & SCHWARTZ, S.M. (1998). Regulated overexpression of the Fas-associated death domain (FADD) protein in seeded vascular smooth muscle cells causes apoptosis followed by recruitment of macrophages. Circulation, 98, 1-597. Abstract.
148. SLOMP, J., GITTENBERGERDEGROOT, A.C., GLUKHOVA, M.A., VANMUNSTEREN, J.C., KOCKX, M.M., SCHWARTZ, S.M. & KOTELIANSKY, V.E. (1997). Differentiation, dedifferentiation, and apoptosis of smooth muscle cells during the development of the human ductus arteriosus. Arterioscler. Thromb. Vascr. Biol., 17, 1003-1009.
149. SPEIR, E., MODALI, R., HUANG, E.S., LEON, M.B., SHAWL, F., FINKEL, T. & EPSTEIN, S.E. (1994). Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science, 265, 391-394.
150. SPYRIDOPOULOS, I., SULLIVAN, A.B., KEARNEY, M., ISNER, J.M. & LOSORDO, D.W. (1997). Estrogen-receptor-mediated inhibition of human endothelial cell apoptosis-Estradiol as a survival factor. Circulation, 95, 1505-1514.
151. STEG, P.G., TAHLIL, O., AUBAILLY, N., CAILLAUD, J.M., DEDIEU, J.F., BERTHELOT, K., LE ROUX, A., FELDMAN, L., PERRICAUDET, M., DENEFLE, P. & BRANELLEC, D. (1997). Reduction of restenosis after angioplasty in an atheromatous rabbit model by suicide gene therapy. Circulation, 96, 408-411.
152. 3 during angiogenesis in vivo. J. Clin. Invest., 98, 426-433.
153. TAN, E.M. (1994). Autoimmunity and apoptosis. J. Exp. Med., 179, 1083-1086.
154. THOMAS, W.A., REINER, J.M., FLORENTIN, F.A., LEE, K.T & LEE, W.M. (1976). Population dynamics of arterial smooth muscle cells. V. Cell proliferation and cell death during initial three months in atherosclerotic lesions induced in swine by hypercholesterolemic diet and intimal trauma. Exp. Mol. Pathol., 24, 360-374.
155. THORNBERRY, N.A. & LAZEBNIK, Y. (1998). Caspases: enemies within. Science, 281, 1312-1316.
156. TOPOL, E.J., CALIFF, R.M., WEISMAN, H.F., ELLIS, S.G., TCHENG, J.E., WORLEY, S., IVANHOE, R., GEORGE, B.S., FINTEL, D., WESTON, M., et al. (1994). Randomized trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC Investigators. Lancet, 343, 881-886.
157. TRAN, J., RAK, J., SHEEHAN, C., SAIBIL, S.D., LACASSE, E., KORNELUK, R.G. & KERBEL, R.S. (1999). Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells. Biochem. Biophys. Res. Commun., 264, 781-788.
158. TRICOT, O., MALLAT, Z., HEYMES, C., LESÈCHE, G. & TEDGUI, A. (2000). Relation between endothelial cell apoptosis and blood flow direction in human atherosclerotic plaques. Circulation, in press.
159. VAN ANTWERP, D.J., MARTIN, S.J., KAFRI, T., GREEN, D.R. & VERMA, I.M. (1996). Suppression of TNF-alpha-induced apoptosis by NF-κB. Science, 274, 787-789.
160. VIRCHOW, R. (1858). Cellular Pathology as Based Upon Physiological and Pathological Histology. p. 361. Birmingham, AL: Classics of Medicine Library.
161. VON DER LEYEN, H., GIBBONS, G.H., MORISHITA, R., LEWIS, N.P., ZHANG, L., KANEDA, Y., COOKE, J.P. & DZAU, V.J. (1995). Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc. Natl. Acad. Sci. U.S.A., 92, 1137-1141.
162. WANG, B.Y., HO, H.K., LIN, P.S., SCHWARZACHER, S.P., POLLMAN, M.J., GIBBONS, G.H., TSAO, P.S. & COOKE, J.P. (1999). Regression of atherosclerosis: role of nitric oxide and apoptosis. Circulation, 99, 1236-1241.
163. WATANABE, Y. & DVORAK, H.F. (1997). Vascular permeability factor/vascular endothelial growth factor inhibits anchorage-disruption-induced apoptosis in microvessel endothelial cells by inducing scaffold formation. Exp. Cell. Res., 233, 340-349.
164. YACHIE, A., NIIDA, Y., WADA, T., IGARASHI, N., KANEDA, H., TOMA, T., OHTA, K., KASAHARA, Y. & KOIZUMI, S. (1999). Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J. Clin. Invest., 103, 129-135.
165. YAMADA, T., AKISHITA, M., POLLMAN, M.J., GIBBONS, G.H., DZAU, V.J. & HORIUCHI, M. (1998). Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin II type 1 receptor action: an in vitro gene transfer study. Life Sci., 63, L289-L295.
166. YUSUF, S., SLEIGHT, P., POGUE, J., BOSCH, J., DAVIES, R. & DAGENAIS, G. The Heart Outcomes Prevention Evaluation Study Investigators. (2000). Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on death from cardiovascular causes, myocardial infarction, and stroke in high-risk patients. N. Engl. J. Med., 342, 145-153. Published erratum appears in N. Engl. J. Med. 2000; 342: 748.
167. 3 integrin inhibits insulin-like growth factor I signaling in vacular smooth muscle cells. Proc. Natl. Acad. Sci. U.S.A., 95, 11217-11222.